Interaction of Plasma Contact Activation Factors with Vascular Endothelium

References

• Adam A., Albert A., Calay G., Closset J., Damas J., Franchimont P. Human kininogens of low and high molecular mass: Quantification by radioimmunoassay and determination of reference values. Clin. Chem 1985; 31: 423–426
   PubMed Web of Science ®Google Scholar
• Becker C. G., Harpel P. C. Alpha2-macroglobulin of human vascular endothelium. J. Exp. Med 1976; 144: 1–9
   PubMed Web of Science ®Google Scholar
• Berrettini M., Schleef R. R., Heeb M. J., Hopmeier P., Griffin J. H. Assembly and expression of an intrinsic factor IX activator complex on the surface of cultured human endothelial cells. J. Biol. Chem 1992; 267: 19833–19839
   PubMed Web of Science ®Google Scholar
• Bevilacqua M. P., Pober J. S., Majeau G. R., Cotran R. S., Gimbrone M. A. J. IL-1 induces biosynthesis and cell surface expression of procoagulant activity of human vascular endothelial cells. J. Exp. Med 1984; 160: 618–623
   PubMed Web of Science ®Google Scholar
• Bevilacqua M. P., Pober J. S., Majeau G. R., Fiers W., Cotran R. S., Gimbrone M. A. Recombinant Tumor Necrosis Factor induces procoagulant activity in cultured human vascular endothelium: Characterization and comparison with the actions of Interleukin 1. Proc. Natl. Acad. Sci 1986; 83: 4533–4537
   PubMed Web of Science ®Google Scholar
• Bhartha K., Muller-Peddinghaus R., Van Rooijen L. A. A. Bradykinin and thrombin effects on polysphingoinositide hydrolysis and prostacyclin production in endothelial cells. Biochem. J 1989; 263: 149–155
   PubMed Web of Science ®Google Scholar
• Bjork I., Olson S. T., Sheffer R. G., Shore J. D. Binding of heparin to human high molecular weight kininogen. Biochemistry 1989; 28: 1213–21
   PubMed Web of Science ®Google Scholar
• Bock P. E., Shore J. D. Protein-protein interaction of blood coagulation. Characterization of a fluoroscein-labeled human high molecular weight kininogen light chain as a probe. J. Biol. Chem 1983; 258: 15079
   PubMedGoogle Scholar
• Bogle R. G., Coade S. B., Moncada S., Pearson J. D., Mann G. E. Bradykinin and ATP stimulate L-arginine uptake and nitric oxide release in vascular endothelial cells. Biochem. Biophys. Res. Comm 1991; 180: 926–932
   PubMed Web of Science ®Google Scholar
• Bönner G., Preis S., Shunk U., Wagmann M., Chrosch R., Toussaint C. Effect of bradykinin on arteries and veins in systemic and pulmonary circulation. J. Cardiovasc. Pharmacol 1992; 20: S21–S27
   PubMed Web of Science ®Google Scholar
• Brash J. L., Scott C. F., ten Hove P., Wojciechowski P., Colman R. W. Mechanism of transient adsorption of fibrinogen from plasma to solid surfaces: role of the contact and fibrinolytic systems. Blood 1988; 71: 932–9
   PubMed Web of Science ®Google Scholar
• Brinkman H. M., Mertens K., Holthuis J., Zwart-Huinink L. A., Grijm K. The activation of human blood coagulation factor X on the surface of endothelial cells: a comparison with various vascular cells, platelets and monocytes. Br J Haematol 1994; 87: 332–342
   PubMed Web of Science ®Google Scholar
• Brunnée T., La Porta C., Reddigari S. R., Salerno V. M., Kaplan A. P., Silverberg M. The activation of factor XI in plasma is dependent upon factor XII. Blood 1993; 81, In Press
   PubMed Web of Science ®Google Scholar
• Clouse L. H., Comp P. C. The regulation of hemosasis: The protein C system. New. Engl. J. Med 1986; 314: 1298–1304
   PubMed Web of Science ®Google Scholar
• Cochrane C. G., Wuepper K. D. The first component of the kinin-forming system in human and rabbit plasma. Its relationship to clotting factor XII (Hageman factor). J. Exp. Med 1971; 134: 986–1004
   PubMed Web of Science ®Google Scholar
• Collier J., Valiance P. Physiological importance of nitric oxide. Br. Med. J 1991; 302: 1289–1290
   PubMed Web of Science ®Google Scholar
• Collier J. G., Nachev C., Robinson B. F. Effect of catecholamines and other vasoactive substances on superficial hand veins in man. Clin. Sci 1972; 43: 455–467
   PubMed Web of Science ®Google Scholar
• Colman R. W., Bagdasarian A., Talamo R. C., Scott C. F., Seavey M., Guimaraes J. A., Pierce J. V., Kaplan A. P. Williams trait. Human kininogen deficiency with diminished levels of plasminogen preactivator and prekahikrein associated with abnormalities of the Hageman factor-dependent pathways. J. Clin. Invest 1975; 56: 1650–1662
   PubMed Web of Science ®Google Scholar
• Cotran R. S. New roles for the endothelium in inflammation and immunity. Am. J. Pathol 1987; 129: 407–413
   PubMed Web of Science ®Google Scholar
• Dunn J. T., Kaplan A. P. Formation and structure of human Hageman factor fragments. J. Clin. Invest 1982; 70: 627
   PubMed Web of Science ®Google Scholar
• Erdös E. G. Kininases. Handbook of experimental pharmacology, E. G. Erdös, Springer 1979; 427–487
   Google Scholar
• Erickson L. A., Schleef R. R., Ny T., Loskutoff D. J. The fibrinolytic system of the vascular wall. Clin. Haematol 1985; 14: 513–530
   PubMedGoogle Scholar
• Esmon C. T. The regulation of natural anticoagulant pathways. Science 1987; 235: 1348–1352
   PubMed Web of Science ®Google Scholar
• Etcheid B. G., Villereal M. L. Coupling of bradykinin receptors to phospholipase C in cultured fibroblasts is mediated by a G-protein. J. Cell Physiol 1989; 140: 264–271
   PubMed Web of Science ®Google Scholar
• Fair D. S., Marlar R. A., Levin E. G. Human endothelial cells synthesize protein S. Blood 1986; 67: 1168–1171
   PubMed Web of Science ®Google Scholar
• Gailani D., Broze G. J., Jr. Factor XI activation in a revised model of blood coagulation. Science 1991; 253: 909–912
   PubMed Web of Science ®Google Scholar
• Ginsberg M. H., Jaques B., Cochrane C. G., Griffin J. H. Urate crystal-dependent cleavage of Hageman factor in human plasma and synovial fluid. J. Lab. Clin. Med 1980; 95: 497–506
   PubMedGoogle Scholar
• Gounaris A. D., Brown M. A., Barrett A. J. Human plasma (α1-cysteine proteinase inhibitor. Purification by affinity chromatography, characterization, and isolation of an active fragment. Biochem. J 1984; 221: 445
   PubMed Web of Science ®Google Scholar
• Gustafson E. J., Schmaier A. H., Wachtfogel Y. T., Kaufman N., Kucich U., Colman R. W. Human neutrophils contain and bind high molecular weight kininogen. J. Clin. Invest 1989; 84: 28–35
   PubMed Web of Science ®Google Scholar
• Heimark R. L., Schwarz S. M. Binding of coagulation factors IX and X to the endothelial cell surface. Biochem. Biophys. Res. Comm 1983; 111: 723–731
   PubMed Web of Science ®Google Scholar
• Henderson L. M., Figueroa C. D., Müller-Esterl W., Bhoola K. D. Assembly of contact phase factors on the surface of the human neutrophil membrane. Blood 1994; 84: 474–482
   PubMed Web of Science ®Google Scholar
• Higashiyama S., Ohkubo I., Ishiguro H., Kunimatsu M., Sawaki K., Sasaki M. Human high molecular weight kininogen as a thiol protease inhibitor: presence of the entire inhibition capacity in the native form of heavy chain. Biochem 1986; 25: 1669–1675
   PubMed Web of Science ®Google Scholar
• Hojima Y., Cochrane C. G., Wiggins R. C., Austen F. F., Stevens R. L. In vitro activation of the contact (Hageman factor) system of plasma by heparin and chondroitin sulfate E. Blood 1984; 63: 1453–1459
   PubMed Web of Science ®Google Scholar
• Ignarro L. J., Harbison R. G., Wood K. S., Kadowitz P. J. Activation of purified soulble guanylate cyclase by endothelium derived relaxing factor from intrapulmonary artery and vein: Stimulation by acetylcholine, bradykinin, and ATP. J. Pharmacol. Exp. Ther 1986; 237: 893–900
   PubMed Web of Science ®Google Scholar
• Issandou M., Darbon J. M. Des-Arg9 bradykinin modulates DNA synthesis, phospholipase C, and protein kinase C in cultured mesangial cells. J. Biol. Chem 1991; 266: 21037–21043
   PubMed Web of Science ®Google Scholar
• Kaplan A. P., Austen K. F. A prealbumin activator of prekallikrein. J. Immunol 1970; 105: 802–811
   PubMedGoogle Scholar
• Kaplan A. P., Austen K. F. A prealbumin activator of prekallikrein I. Derivation of activators of prekallikrein from active Hageman factor digestion with plasmin. J. Exp. Med 1971; 133: 672–712
   Google Scholar
• Kaplan A. P., Silverberg M. The coagulation-kinin pathway of human plasma. Blood 1987; 70: 1–15
   PubMed Web of Science ®Google Scholar
• Key N. S., Vercellotti G. M., Winkelmann J. C., Moldow C. F., Goodman J. L., Esmon N. L., Esmon C. T., Jacob H. S. Infection of vascular endothelial cells with herpes simplex virus enhances tissue factor activity and reduces thrombomodulin expression. Proc. Natl. Acad. Sci., USA 1990; 87: 7095–7099
   PubMed Web of Science ®Google Scholar
• Kuna P., Kaplan A. P., Reddigari S. R. Human high molecular weight kininogen binds to human umbilical cord endothelial cells through its heavy chain. Blood 1990; 76: 426a
   Google Scholar
• Lieberman G. E., Lewis G. P., Peters T. J. A membrane bound enzyme in rabbit aorta capable of inhibiting ADP induced platelet aggregation 1977; 2: 330–332
   Google Scholar
• Linz W., Weimer G., Schölkens B. A. ACE inhibition induces NO-formation in cultured bovine endothelial cells and protects isolated ishcemic rat hearts. J. Mol. Cell Cardiol 1992; 24: 909–919
   PubMed Web of Science ®Google Scholar
• Linz W., Wiemer G., Schölkens B. A. Contribution of bradykinin to the cardiovascular effects of ramipril. J. Cardiovasc. Pharmacol 1993; 22: S1–S8
   Web of Science ®Google Scholar
• Maier M., Austen K. F., Spragg J. Characterization of the procoagulant chain derived from high molecular weight kininogen (Fitzgerald factor) by tissue kallikrein. Blood 1983; 62: 457
   PubMed Web of Science ®Google Scholar
• Mandle R. J., Colman R. W., Kaplan A. P. Identification of prekallikrein and high molecular weight kininogen as a complex in plasma. Proc. Natl. Acad. Sci., USA 1976; 73: 4179–4183
   PubMed Web of Science ®Google Scholar
• Mandle R. J. J., Kaplan A. P. Hageman factor substrates. II. Human plasma prekallikrein. Mechanism of activation by Hageman factor and participation in Hageman factor-dependent fibrinolysis. J. Biol Chem 1977; 252: 6097
   PubMed Web of Science ®Google Scholar
• Marlar R. A., Kleiss A. J., Griffin J. H. Mechanism of action of human activated protein C, a thrombin dependent anticoagulant enzyme. Blood 1982; 59: 1067–1072
   PubMed Web of Science ®Google Scholar
• Mason D. T., Melmon K. L. Effects of bradykinin on forearm venous tone and vascular resistance in man. Circ. Res 1965; 17: 106–113
   PubMed Web of Science ®Google Scholar
• Mason J. W., Kleeberg U., Dolan P., Colman R. W. Plasma kallikrein and Hageman factor in gram-negative bacteremia. Ann. Int. Med 1970; 73: 545–551
   PubMed Web of Science ®Google Scholar
• McIntyre T. M., Zimmerman G. A., Satoh K., Prescott S. M. Cultured endothelial cells synthesize both platelet activating factor and prostacyclin in response to histamine, bradykin, and ATP. J. Clin. Invest 1985; 76: 271–280
   PubMed Web of Science ®Google Scholar
• Meier H. L., Pierce J. V., Colman R. W., Kaplan A. P. Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein. J. Clin. Invest 1977; 60: 18–31
   PubMed Web of Science ®Google Scholar
• Meloni F. J., Gustafson E. J., Schmaier A. H. High molecular weight kininogen binds to platelets by its heavy and light chains and when bound has altered susceptibility to kallikrein cleavage. Blood 1992; 79: 1233–1244
   PubMed Web of Science ®Google Scholar
• Mori K., Nagasawa S. Studies on human high molecular weight (HMW) kininogen. IL. Structural change in HMW kininogen by the action of human plasma kallikrein. J. Biochem 1981; 89: 1465–1473
   PubMed Web of Science ®Google Scholar
• Reddigari S. R., Kaplan A. P. Quantification of human high molecular weight kininogen by immunoblotting with a monoclonal anti-light chain antibody. J. Immunol. Meth 1989; 19–25
   PubMed Web of Science ®Google Scholar
• Reddigari S. R., Kuna P., Miragliotta G. F., Shibayama Y., Nishikawa K., Kaplan A. P. Human high molecular weight kininogen binds to human umbilical vein endothelial cells via its heavy and light chains. Blood 1993a; 81: 1306–1311
   PubMed Web of Science ®Google Scholar
• Reddigari S. R., Shibayama Y., Brunnée T., Kaplan A. P. Human factor XII (Hageman factor) and high molecular weight kininogen compete for the same binding site on human umbilical vein endothelial cells. J. Biol. Chem 1993b; 268: 11982–11987
   PubMed Web of Science ®Google Scholar
• Revak S. D., Cochrane C. G., Griffin J. H. The binding and cleavage characteristics of human Hageman factor during contact activation: A comparison of normal plasma with plasma deficient in factor XI, prkallikrein or high molecular weight kininogen. J. Clin. Invest 1977; 58: 1167
   Google Scholar
• Revak S. D., Cochrane C. G., Johnston A. R., Hugli T. E. Structural changes accompanying enzymatic activation of human Hageman factor. J. Clin. Invest 1974; 54: 619
   PubMed Web of Science ®Google Scholar
• Roeise O., Bouma B. N., Stadaas J. O., Aasen A. O. Dose dependence of endotoxin-induced activation of the plasma contact system: an in vitro study. Circ. Sh 1988; 26: 419–430
   PubMedGoogle Scholar
• Salvesen G., Parkes C., Abrahamson M., Grubb A., Barrett A. J. Human low-Mr kininogen contains three copies of a cystatin sequence that are divergent in structure and in inhibitory activity for cyhsteine proteinases. Biochem. J 1986; 234: 429–434
   PubMed Web of Science ®Google Scholar
• Scarpati E. M., Sadler J. E. Regulation of Endothelial Cell Coagulant Properties - Modulation of Tissue Factor, Plasminogen Activator Inhibitors, and Thrombomodulin by Phorbol 12–Myristate 13–Acetate and Tumor Necrosis Factor. J. Biol. Chem 1989; 264: 20705–20713
   PubMed Web of Science ®Google Scholar
• Schiffman S., Mannhalter C., Tynerk D. Human high molecular weight kininogen. Effects of cleavage by kallikrein on protein structure and procoagulant activity. J. Biol. Chem 1980; 255: 6433–6438
   PubMed Web of Science ®Google Scholar
• Schini V. B., Boulanger C., Regoli D., Vanhoutte P. M. Bradykinin stimulates the production of cyclic GMP via activation of B, kinin receptors in cultured porcine aortic endothelial cells. J. Pharmacol. Exp. Ther 1990; 252: 581–585
   PubMed Web of Science ®Google Scholar
• Schmaier A. H., Kuo A., Lundberg D., Murray S., Cines D. B. The expression of high molecular weight kininogen on human umbilical vein endothelial cells. J. Biol. Chem 1988; 203: 16327–16333
   Google Scholar
• Schmaier A. H., Silver L., Adams A. L., Fischer G. C., Munoz P. C., Vroman L., Colman R. W. The effects of high molecular weight kininogen on surface-adsorbed fibrinogen. Thromb Res 1984; 33: 51
   PubMed Web of Science ®Google Scholar
• Schousboe I. The inositol-phospholipid-accelerated activation of prekallikrein by activated factor XII at physiological ionic strength requires zinc ions and high-Mr kininogen. Eur J. Biochem 1990; 193: 495–499
   PubMedGoogle Scholar
• Scott C. F., Colman R. W. Fibrinogen blocks the autoactivation and thrombin-mediated activation of factor XI on dextran sulfate. Proc. Natl. Acad. Sci., USA 1992; 89: 11189–11103
   PubMed Web of Science ®Google Scholar
• Shimada T., Sugo T., Kato H., Yoshida K., Iwanaga S. Activation of factor XII and prekallikrein with polysaccharide sulfates and sulfatides: Comparison with kaohn-mediated activation. J. Biochem 1985; 97: 429–439
   PubMed Web of Science ®Google Scholar
• Silverberg M., Diehl S. V. The autoactivation of factor XII (Hageman factor) induced by low Mr heparin and dextran sulfate. Biochem. J 1987; 248: 715–720
   PubMed Web of Science ®Google Scholar
• Silverberg M., Dunn J. T., Garen L., Kaplan A. P. Autoactivation of Human Hageman Factor. J. Biol. Chem 1980a; 255: 7281–7286
   PubMed Web of Science ®Google Scholar
• Silverberg M., Kaplan A. P. Human Hageman factor and its fragments. Methods Enzymol 1988; 163: 68–80
   PubMed Web of Science ®Google Scholar
• Silverberg M., Nicoll J. E., Kaplan A. P. The mechanism by which the light chain of cleaved HMW-kininogen augments the activation of prekallikrein, factor XI, and Hageman factor. Thromb. Res 1980b; 70: 173–189
   Google Scholar
• Stem D., Nawroth P., Marcum J., Handley D., Kisiel W., Rosenberg R., Stem K. Interaction of antithrombin III with bovine aortic segments. J. Clin. Invest 1985; 75: 272–279
   PubMed Web of Science ®Google Scholar
• Stern D. M., Drillings M., Kisiel W., Nawroth P. P., Nossel H. L., La Gamma K. S. Activation of factor IX bound to bovine aortic endothelial cells. Proc. Natl. Acad. Sci., USA 1984; 81: 913–917
   PubMed Web of Science ®Google Scholar
• Stolpen A. H., Guinan E. C., Fiers W., Pober J. S. Recombinant Tumor Necrosis Factor and Immune Interferon act singly and in combination to reorganize Human Vascular Endothelial Cell Monolayers. Am. J. Pathol 1986; 123: 16–24
   PubMed Web of Science ®Google Scholar
• Sueyoshi T., Enjyoji K., Shimada T., Kato H., Iwanaga S., Bando Y., Kominami E., Katunuma N. A new function of kininogens as thiol-proteinase inhibitors: inhibition of papain and cathepsins B, H and L by bovine, rat and human plasma kininogens. FEES Lett 1985; 182: 193–195
   PubMed Web of Science ®Google Scholar
• Tait J., Fujikawa K. Identification of the binding site plasma prekallikrein in human high molecular weight kininogen. J. Biol. Chem 1986; 261: 15396–15401
   PubMedGoogle Scholar
• Tait J., Fujikawa K. Primary structure requirements for the binding of human high molecular weight kininogen to plasma prekallikrein and factor XI. J. Biol. Chem 1987; 262: 11651–11656
   PubMed Web of Science ®Google Scholar
• Thompson R. E., Mandle R. J., Kaplan A. P. Association of factor XI and high molecular weight kininogen in human plasma. J. Clin. Invest 1977; 60: 1376
   PubMed Web of Science ®Google Scholar
• Thompson R. E., Mandle R. J., Kaplan A. P. Characterization of human high molecular weight kininogens: Pro-coagulant activity associated with the light chain of kinin-free high molecular weight kininogen. J. Exp. Med 1978; 147: 488–499
   PubMed Web of Science ®Google Scholar
• van Blitterswijk W. J., Hilkmann H., de Widt J., van der Bend R. L. Phospholipid metabolism in bradykinin-stimulated human fibroblasts. I. Biphasic formation of diacylglycerol from phosphatidylinositol phosphatidylcholine, controlled by protein kinase C. J. Biol. Chem 1991a; 266: 10337–10343
   PubMed Web of Science ®Google Scholar
• van Blitterswijk W. J., Hilkmann H., de Widt J., van der Bend R. L. Phospholipid metabolism in bradykinin-stimulated human fibroblasts. II. Phosphatidylcholine breakdown by phospholipases C and D: Involvement of protein kinase C. J. Biol. Chem 1991b; 266: 10344–10350
   PubMed Web of Science ®Google Scholar
• van lwaarden F., de Groot P. G., Bouma B. N. The binding of high molecular weight kininogen to cultured human endothelial cells. J. Biol. Chem 1988a; 263: 4698–4703
   PubMed Web of Science ®Google Scholar
• van Iwaarden F., de Groot P. G., Sixma J. J., Berrettini M., Bouma B. N. High molecular weight kininogen is present in cultured human endothelial cells: Localization, isolation and characterization. Blood 1988b; 71: 1268–1276
   PubMed Web of Science ®Google Scholar
• van Mourik J. A., Laurence D. A., Loskutoff D. J. Purification of plasminogen activator inhibitor synthesized by endothelial cells. J. Biol. Chem 1984; 259: 14914–14921
   PubMed Web of Science ®Google Scholar
• Vroman L., Adams A. L., Fischer G. C., Munoz P. C. Interaction of high molecular weight kininogen, factor XII and fibrinogen in plasma at interfaces. Blood 1980; 55
   PubMedGoogle Scholar
• Wachtfogel Y. T., DeLa C. R., Kunapuli S. P., Rick L., Miller M., Schultze R. L., Altieri D. C., Edgington T. S., Colman R. W. High molecular weight kininogen binds to Mac-1 on neutrophils by its heavy chain (domain 3) and its light chain (domain 5). J. Biol. Chem 1994; 269: 19307–12
   PubMed Web of Science ®Google Scholar
• Wallis W. J., Harlan J. M. Effector functions of endothelium in inflammatory and immunologic reactions. Immunopathol. Res 1986; 5: 73–103
   PubMedGoogle Scholar
• Weksler B. B., Marcus A. J., Jaffe E. A. Synthesis of prostaglandin 12 (prostacyelin) by cultured human and bovine endothelial cells. Proc. Natl. Acad. Sci., USA 1977; 74: 3922–3926
   PubMed Web of Science ®Google Scholar
• Wiggins R. C., Cochrane C. G. The autoactivation of rabbit Hageman factor. J. Exp. Med 1979; 150: 1122–1133
   PubMed Web of Science ®Google Scholar
• Wiggins R. C., Loskutoff D. J., Cochrane C. G., Griffin J. H., Edgington T. S. Activation of rabbit Hageman factor by homogenates of cultured rabbit endothelial cells. J. Clin. Invest 1980; 65: 197–206
   PubMed Web of Science ®Google Scholar
• Woo J., Cannon D. C. Metabolic intermediates and inorganic ions. Clinical Diagnosis and Management by Laboratory Methods, J. B. Henry. W. B. Saunders. 1984; 130–164
   Google Scholar
• Zini J. M., Schmaier A. H., Cines D. B. Bradykinin regulates the expression of kininogen binding sites on endothelial cells. Blood 1993; 81: 2936–2946
   PubMed Web of Science ®Google Scholar